Daiichi Sankyo Co. Ltd. - Liabilities and Stockholders Equity
Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Liabilities-and-Stockholders-Equity" stands at 3.46 Trillion Japanese Yens as of 06/30/2025, the highest value since 06/30/2024.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Liabilities and Stockholders Equity" stands at 3.46 Trillion JPY. This represents an increase of 0.1 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.6542 percent compared to the value the year prior.
The 1 year change in percent is 0.6542.
The 3 year change in percent is 50.78.
The 5 year change in percent is 67.68.
The 10 year change in percent is 79.85.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +139.33%.
The Serie's change in percent from it's maximum value, on 03/31/2024, to it's latest available value, on 06/30/2025, is -0.0438%.
Liabilities and Stockholders Equity for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Liabilities and Stockholders Equity | 905,699,262,464.00 |
 | Johnson & Johnson - Liabilities and Stockholders Equity | 486,508,953,600.00 |
 | AbbVie Inc - Liabilities and Stockholders Equity | 399,570,305,024.00 |
 | Roche Holding AG - Liabilities and Stockholders Equity | 317,433,206,677.55 |
 | AstraZeneca PLC - Liabilities and Stockholders Equity | 280,205,508,085.11 |